These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8272262)

  • 1. GM-1 ganglioside administration combined with physical therapy restores ambulation in humans with chronic spinal cord injury.
    Walker JB; Harris M
    Neurosci Lett; 1993 Oct; 161(2):174-8. PubMed ID: 8272262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside.
    Geisler FH; Dorsey FC; Coleman WP
    N Engl J Med; 1991 Jun; 324(26):1829-38. PubMed ID: 2041549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-1 ganglioside and motor recovery following human spinal cord injury.
    Geisler FH
    J Emerg Med; 1993; 11 Suppl 1():49-55. PubMed ID: 8445203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM-1 ganglioside in human spinal cord injury.
    Geisler FH; Dorsey FC; Coleman WP
    J Neurotrauma; 1992 May; 9 Suppl 2():S517-30. PubMed ID: 1613811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-1 ganglioside in human spinal cord injury.
    Geisler FH; Dorsey FC; Coleman WP
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S407-16. PubMed ID: 1588631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury.
    Geisler FH; Dorsey FC; Coleman WP
    Ann Emerg Med; 1993 Jun; 22(6):1041-7. PubMed ID: 8503523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside.
    Geisler FH; Dorsey FC; Coleman WP
    N Engl J Med; 1991 Dec; 325(23):1659-60. PubMed ID: 1944464
    [No Abstract]   [Full Text] [Related]  

  • 8. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials of pharmacotherapy for spinal cord injury.
    Geisler FH
    Ann N Y Acad Sci; 1998 Jun; 845():374-81. PubMed ID: 9668370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury.
    Fehlings MG; Bracken MB
    Spine (Phila Pa 1976); 2001 Dec; 26(24 Suppl):S99-100. PubMed ID: 11805615
    [No Abstract]   [Full Text] [Related]  

  • 11. GM-1 ganglioside for spinal-cord injury.
    Landi G; Ciccone A
    N Engl J Med; 1992 Feb; 326(7):493; author reply 494. PubMed ID: 1732786
    [No Abstract]   [Full Text] [Related]  

  • 12. Ganglioside-induced regeneration and reestablishment of axonal continuity in spinal cord-transected rats.
    Bose B; Osterholm JL; Kalia M
    Neurosci Lett; 1986 Jan; 63(2):165-9. PubMed ID: 2419804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa therapy in incomplete spinal cord injury.
    Maric O; Zörner B; Dietz V
    J Neurotrauma; 2008 Nov; 25(11):1303-7. PubMed ID: 19061374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has GM1 ganglioside been shown to be effective in the restoration of neurologic function in persons with chronic spinal cord injury? A critique of an article by Judith B. Walker and Michelle Harris.
    Klose KJ; Calancie B
    Neurosci Lett; 1994 Aug; 176(2):277-80. PubMed ID: 7830964
    [No Abstract]   [Full Text] [Related]  

  • 15. GM-1 ganglioside for spinal-cord injury.
    Schönhöfer PS
    N Engl J Med; 1992 Feb; 326(7):493; author reply 494. PubMed ID: 1732787
    [No Abstract]   [Full Text] [Related]  

  • 16. GM1 gangliosides in the treatment of spinal cord injury: report of preliminary data analysis.
    Geisler FH; Dorsey FC; Coleman WP
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):515-21. PubMed ID: 2130666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylprednisolone and ganglioside GM-1 on a spinal lesion: a functional analysis.
    Carvalho MO; Barros Filho TE; Tebet MA
    Clinics (Sao Paulo); 2008 Jun; 63(3):375-80. PubMed ID: 18568249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Sygen multicenter acute spinal cord injury study.
    Geisler FH; Coleman WP; Grieco G; Poonian D;
    Spine (Phila Pa 1976); 2001 Dec; 26(24 Suppl):S87-98. PubMed ID: 11805614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
    Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
    Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Pharm Pract Manag Q; 2000 Apr; 20(1):21-7. PubMed ID: 10947539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.